The transmembrane envelope glycoprotein (gp41) of human immunodeficiency virus type 1 possesses four consensus sites (Asn-X-Ser/Thr) for the incorporation of N-linked sugars situated on the extracellular domain of the molecule. The purpose of this investigation was to determine the significance of each of these sites in relation to the structure and function of the viral envelope glycoprotein. Each of the four sites was removed by in vitro mutagenesis of gpl60 sequence in the non-infectious viral clone pEVd1443, so that amino acids 616, 621, 642 and 679 were each changed from asparagine to serine. The effects of mutagenesis were assessed by syncytium assay after wild-type or mutant envelope clones had been transfected into CD4 + HeLa cells. Removal of the glycosylation site at position 642 resulted in the synthesis of precursor gpl60 that was neither cleaved, to give gpl20 and gp41, nor transported to the plasma membrane of transfected cells. A consequence of these events was that envelope mutant 642 failed to induce syncytia between neighbouring cells in which it had been expressed. The results of this study indicate that N-linked glycosylation of Asn-642 in the glycoprotein produced by the pEVd1443 expression system is necessary for the correct intracellular processing of gpl60 to yield surface-expressed, fusogenic gp41.
Introduction
The envelope protein of human immunodeficiency virus type 1 (HIV-1) is translated as an 88K precursor protein (Allan et al., 1985) which, during passage through the endoplasmic reticulum (ER) and Golgi apparatus of the infected cell, is heavily glycosylated to form the precursor glycoprotein gpl60. Subsequently this precursor is cleaved in the Golgi network of the cell (Willey et al., 1988a) by a furin-like enzyme (Morikawa et al., 1993) to yield mature surface envelope glycoprotein (gpl20) and transmembrane envelope glycoprotein (gp41). This cleavage is necessary for the production of infectious viral particles (McCune et al., 1988) . After cleavage, gpl20 and gp41 are present as a non-covalently associated heterodimer which is organized oligomerically on the surface of viral particles (Schawaller et al., 1989) , The gpl20 envelope component targets the virus to host cells that express the CD4 receptor on their plasma membrane (Dalgleish et al., 1984) . Following recepto~gpl20 int Present address: Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, U.K.
teraction, gp41 initiates fusion of the viral envelope with the host cell plasma membrane (Freed et al., 1990) and the viral nucleocapsid is released into the cytoplasm to initiate infection.
Both envelope glycoproteins contain highly conserved consensus sequences (AsmX-Ser/Thr) which direct the incorporation of N-linked sugars (Kornfeld & Kornfeld, 1985; Willey et al., 1986) . HIV-I gp41 contains four such N-linked glycosylation sites which are conserved in a number of divergent HIV-1 isolates . The aim of this study was to investigate the in vitro significance of each of the glycosylation sites of gp41 in relation to the structure and function of the envelope glycoprotein. This was performed by removing the sites individually from the sequence encoding gp41 in pEVd1443. This plasmid contains a genetically stable clone of HIV-1 which is both non-infectious and nonreplicative, lacking gag and pol genes, but retains the viral control elements for protein expression and produces full-length HIV-1 envelope glycoprotein (Felser et al., 1989) . Mutagenesis generated four clones, and the effects of a given mutation were assessed initially by syncytium assay in CD4 + HeLa cells transfected with the plasmid DNA encoding wild-type or mutant envelope glycoprotein.
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Syncytium formation in vitro is dependent on the interaction of viral envelope-expressing cells with cells bearing surface CD4 receptor (Sodroski et al., 1986; Lifson et al., 1986) . Experiments using this system indicated that mutation of HIV-1 envelope at amino acid 642 from N to S in pEVd 1443 prevented cleavage of the gpl60 envelope precursor. This stopped surface expression of envelope proteins and thereby abolished their ability to induce syncytia. The non-infectious system employed here was utilized in view of data yielded by a previous study into the role of N-glycosylation sites within a conserved domain ofgpl20. That study used the infectious proviral clone pNL-43 and determined that experimentally induced envelope mutations could be nullified by compensatory mutations elsewhere in the viral envelope sequence (Willey et al., 1988b) .
Methods
Generation of single point mutations in pEVd1443,
The synthetic oligonucleotides used to introduce single point mutations into pEVd1443 envelope were made with an Applied Biosystems synthesizer. The sequence for each is shown in Fig. 1 . The 2-7 kb BamHI-EeoRI fragment containing the four potential N-linked glycosylation sites in gp41 was excised from pEVd1443 (a kind gift from J. Felser) and ligated into M13mpl9. This was then used to generate a uridine template for mutagenesis (Kunkel et at., I987) . The presence of the correct point mutation was confirmed by sequencing across the appropriate region of a clone using the dideoxynucleotide chain termination method (Sander et al., 1977) . Following sequence confirmation, the 2.7 kb BamHI EcoRI fragment was excised and ligated into similarly digested pEVd1443. This procedure generated four mutant clones of pEVd1443 each of which contained a single point mutation causing an amino acid change of Asn to Ser at residues 616, 621,642 and 679, respectively (see Fig. 1 ).
Transfer of gp41 mutant and wild-type pEVd1443 clones into the Q7 vector. Env genes of pEVd1443 wild-type and the four mutants were rescued by PCR using VENT DNA polymerase (New England Biolabs) and primers BCFHO, 5' GAATAAGAGCTCGAGCAGAAGA-CAGTGGCAATGA 3', and ENVR, 5' CAACCAGAATTCTTTTT-GACCACTTGCCACCCATCTTA Y. The 2-6 kb PCR products were digested with XhoI and EcoRI and cloned into pQ7 (R. Daniels, details of construction to be published) downstream of a synthetic T7 promoter sequence. Following transient expression trials, the env pQ7 constructs were sequenced using Sequenase version 2.0 (USB) to ensure fidelity of the env genes.
Antibodies. Mouse monoclonal antibodies were as follows. Affinitypurified anti-gpl60/120 of HIV-1 (ADP301/221) was obtained from the MRC AIDS Directed Programme, anti-gp4t of HIV-I (NEA-9303) was purchased from New England Nuclear and anti-human helper/ inducer T cell CD4 (DAKO-T4, MT310) was from Dakopatts. Affinitypurified goat anti-mouse IgG horseradish peroxidase conjugate (W402B) was purchased from Promega. Affinity-purified goat antimouse lgG rhodamine B conjugate was from Tago. (c), and constituted a noninfectious clone of the virus lacking gag and pol regions of the genome (Felser et al., 1989) . The 2-7 kb BamHI-EcoRI fragment of the viral envelope, coding for gp41, was removed and ligated into Mt3 mplg.
SDS-PAGE
Coding sequences for each of the four potential glycosylation sites on gp41 were then point-mutated so that the consensus sequence As~X Ser/Thr would no longer be generated. Each consensus site Asn was altered to Ser. The mutagenic oligonucleotide used is given beneath each mutant and the nucleotide in lower case represents the change from the published sequence (A to G). Mutated fragments coding for gp41 were subsequently re-introduced to pEVd1443 and the resultant plasmids used to transfect cells as described. Mutants were numbered to denote the amino acid changed in the transmembrane envelope glycoprotein. Numbering is derived from the system used for HIV-I~R v ).
aliquot of cleared supernatant was mixed with an equal volume of 2 × electrophoresis sample buffer, containing 5 % (v/v) 2-mercaptoethanol and heated to 95 °C for 5 min prior to electrophoresis on an 8.5 % polyacrylamide gel as described by Laemmli (1970) . Semi-dry Western blotting onto nitrocellulose filters (Schleicher and Schuell; 0.45 tam) was performed using techniques described by Burnette et al. (198l) .
Filters were processed for the detection of blotted antigen by the enhanced chemiluminescence system (ECL) using the Amersham ECL reagent protocol (RPN 2106) and Hyperfilm-ECL (RPN 2103). Primary mouse monoclonal anti-envelope antibody was used at 1/200 dilution and the secondary goat anti-mouse lgG antibody at 1/5000 dilution. (Scherer et al., 1953) were cultured at 37 °C in an atmosphere of 5% (v/v) CO 2 with complete Dulbecco's modified Eagle's medium (DMEM; Gibco), lacking sodium pyruvate and containing 4.5 g of glucose/l, penicillin and streptomycin at 100 lag/ml and 10% fetal calf serum (FCS). HeLa T4 (CD4 +) cells (Maddon et al., 1986) were maintained in the same medium with the addition of 500 gg/ml geneticin (Gibco) to select for CD4 recombinant cells.
Trans]ection of tissue culture cells for transient expression of the HIV-1 envelope. HeLa cells
Transfection protocols"
Method (i). Cells were grown to 70 % confluence on 35 mm Nunc tissue culture plastic wells, or on 2.5 cm z glass coverslips. Each monolayer was transfected with 2 gg of mutant or wild-type pEVd 1443 plasmid DNA and 10 gg of N-[1-(2,3-dioleoyloxy) propyl]-N,N,Ntrimethyl-ammoniummethylsulphate (DOTAP; Boehringer Mannheim) in 2 ml of DMEM according to the manufacturer's instructions. Forty-eight h after transfection the cells were either fixed, for staining, or lysed ~br electrophoretic analysis as described above.
Method (ii). Cells grown as above, were infected with recombinant vaccinia virus vTF7-3 (Fuerst et al., 1987) for 1 h at 37 °C in FCS-free DMEM. Virus was then removed and the cells were transfected with 2 gg of HIV-1 envelope-Q7 plasmid DNA and 10 lag of DOTAP in 2 ml of DMEM and incubated for a further 16 h prior to lysis for electrophoretic analysis.
Staining of cells with toluidine blue. Cells grown in 35 mm wells were transfected as described in method (i) and after 48 h washed once with PBS and fixed by the addition of PBS containing 2-5% (w/v) glutaraldehyde for 30 rain at room temperature. Cells were then washed twice with PBS and stained by addition of a 1% (w/v) solution of toluidine blue in PBS for 15 min (Godley et al., 1992) . After staining the cells were washed three times in PBS and observed and photographed on an Olympus CK2 inverted microscope at 100x magnification.
Indirect immunofluorescence microscopy of transfected cells. The protocol used was a modification of the methods described by Ash et al. (1977) . HeLa or HeLa T4 cells were plated at a dilution of 1 : 10 in DMEM onto 2.4 cm 2 glass coverslips in 35 mm six-well dishes and incubated at 37 °C for 24 h until 70% confluent. Transfection was performed using method (i) with 2 lag of plasmid DNA from a given mutant clone. After 48 h incubation coverslips were washed with PBS and the cells were fixed with either 95:5 (v/v) ethanol:acetic acid for 10 min at -20 °C or 3 % paraformaldehyde in PBS for 10 min at room temperature. HIV-1 envelope antigens were detected using affinitypurified mouse monoclonal anti-gp160/120 at 1/100 dilution as the primary antibody and goat anti-mouse IgG-rhodamine B conjugate at 1/200 dilution, as the secondary label. The CD4 receptor was detected with mouse monoclonal anti-CD4 antibody using the same protocol. Cells were observed by epifluorescence microscopy with a Nikon Labophot-2A microscope, with microflex UFX-DX attachment, at an excitatory wavelength of 546 nm. Photomicrographs were taken at 1000 x magnification with Ilford ASA 400 black and white film.
Results
Expression of mutated and wild-type pEVd1443 envelope glycoproteins in HeLa T4 cells
Using transfection method (i), plasmids carrying envelope mutants N616S, N621S, N642S, N679S and wildtype envelope sequences were transfected into HeLa T4 cells and fixed for toluidine blue staining. Fig. 2 shows cells 48 h after transfection. Mutant N642S did not induce the formation of syncytia; after transfection cells had the same appearance as those treated with DOTAP in the absence of plasmid DNA. When cells were transfected with either wild-type envelope plasmid or mutants N616S, N621S and N679S the degree of syncytium induction observed was equivalent; this indicated that phenotypically these envelope mutants were analogous to wild-type envelope. Syncytium induction by HIV-1 is dependent on gpl20-CD4 interaction followed by gp41-mediated membrane fusion. When the above procedure was carried out in HeLa cells, which lack the CD4 receptor, syncytia were not observed after expression of wild-type or mutant forms of the envelope protein (data not shown).
Western blot analysis of envelope glycoproteins gp160/120 expressed in HeLa T4 cells
HeLa T4 cells were transfected with plasmids encoding either wild-type or mutant envelope sequences using method (i). Forty-eight h post-transfection cells were lysed in LB. Aliquots of lysate were subjected to SDS-PAGE and Western-blotted onto nitrocellulose. Blots were treated with ADP301/221, a monoclonal antibody specific for the carboxy terminus of gpl20, 20 amino acid residues upstream of the REKR cleavage motif (Morikawa et al., 1993) , and then developed using ECL reagents. The results demonstrated that envelope mutant N642S expressed in this cell line was not cleaved to yield gpl20 from the precursor gpl60 glycoprotein, which was the only species detected; see Fig. 3 . In contrast, in mutants N616S, N621S and N679S envelope molecules were cleaved to an extent similar to that observed with wild-type envelope protein and both gpl20 and gp160 were detected. The absence of gp120, as assayed by Western blot, following expression of mutant N642S implied that gp41 was absent.
Detection of HIV-1 envelope glycoproteins and the CD4 receptor by indirect immunofluorescence
HeLa T4 cells grown on glass coverslips were transfected, using method (i), with plasmids for mutant or wild-type envelope gp41. Forty-eight h post-transfection cells were fixed with a 95:5 mixture of ethanol/acetic acid at -2 0 °C and envelope antigens were observed by indirect immunofluorescence as described. In the cases of cells Fig. 2 . Syncytium formation in HeLa T4 cells, stained with toluidine blue, 48 h after monolayers were transfected (method i) with 2 gg of a given mutant or wild-type plasmid DNA. N642S (d) was phenotypically incapable of syncytium induction relative to wild-type envelope (a). Mutant N642S-transfected cells had the same appearance as mocktransfected cells (f). Conversely mutants N616S, N621S and N679S were observed to induce syncytium formation with the same efficiency (b, c and e, respectively) as wild-type envelope.
expressing wild-type envelope protein or mutants N616S, N621S and N679S, neighbouring cells formed syncytia mediated by functional gp41 (Fig. 4) . Mutant N642S however was incapable of syncytium induction even though it had been expressed (Fig. 4, panel D) . The observed'twinning' effect, i.e. the detection of expression of this mutant in pairs of cells is a function of the method used, which facilitates the detection of antigens that are present both intracellularly and on the plasma membrane. It was taken that such an effect was due to expression of the envelope protein by a cell that had divided once during the 48 h post-transfection period. In addition the staining pattern observed for this mutant appeared to be concentrated in the perinuclear region of the transfected cell, possibly in the ER (LippincottSchwartz et al., 1990) . Mock-transfected cells did not show staining. When cells were fixed with 3 % paraformaldehyde, which enables the detection of surface antigens exclusively, wild-type and mutant envelope downstream of a T7 promoter. Envelope gene expression was driven by T7 RNA polymerase provided in trans by vaccinia virus vTF7-3, using transfection method (ii). Lysates were prepared from HeLa cells transfected with mutant or wild-type envelope plasmids and aliquots were analysed by SDS PAGE. Western blots of this material were then probed with the anti-gp41 antibody. Functional wild-type and mutant envelope glycoproteins N616S, N621S and N679S, respectively, were all found to be cleaved, to yield gp41 (Fig. 6) . The gp41 species detected in mutant forms exhibited an altered electrophoretic mobility relative to wild-type. This corresponded with a reduction in M r of 1500 which could be accounted for by the loss of a single glycosylation moiety. Precursor gp160 was also detected by this monoclonal antibody. For mutant N642S only gp160 was detected, thereby confirming the lack of precursor processing conferred by this mutation.
proteins N616S, N621S and N679S were detected on the plasma membrane whereas mutant N642S envelope glycoprotein was not (Fig. 5) . This confirmed that the viral envelope glycoproteins expressed by mutant N642S did not reach the plasma membrane. As a positive control for the detection of antigens on the plasma membrane, and to confirm the presence of the CD4 receptor, HeLa T4 cells were fixed with 3% paraformaldehyde and labelled with monoclonal anti-CD4 antibodies (Fig. 5, panel F) .
Western blot analysis of envelope glycoproteins gp41 and gpl60 expressed in HeLa cells'
From the data obtained it was evident that gpl60 was expressed when wild-type and mutant envelope plasmids were used to transfect HeLa T4 cells. However, cleavage of gpl60 to yield functional gpl20 and gp41, judged by the ability to induce syncytia (see Fig. 2 ) did not occur when mutant envelope protein N642S was used to transfect cells. By inference, envelope mutants N616S, N621S and N679S and wild-type all had fusioncompetent gp41 but envelope mutant N642S did not. Experiments to detect gp41 on Western blots using antigp41 NEA-9303 antibody were performed in parallel to those shown in Fig. 3 (results not shown) . Our observations, however, indicated that the level of gp41 expression required to permit syncytium formation, using the pEVd1443 system, was below the level detectable with this antibody and the ECL method employed. Therefore a system that would allow increased levels of the envelope proteins to be expressed was developed. This was achieved by excising mutant or wildtype envelope sequences from respective pEVd1443 vector plasmids and ligating them into the pQ7 plasmid,
D i s c u s s i o n
The envelope glycoproteins of HIV-1, gpl20 and gp41, contain several conserved domains and sites for the incorporation of N-linked sugars (Willey et al., 1986) . Such conservation indicates that these regions are of significance to the structure and function of these viral envelope proteins. The data presented here demonstrate that removal of a single N-linked glycosylation site within the sequence of gp41, at Asn-642, disrupts the proteolytic processing and transport of the envelope protein precursor gpl60, resulting in a loss of HIV glycoprotein-mediated cell fusion. This implies that glycosylation of gp41 at this site is required for correct post-translational modification and the subsequent generation of fusion-competent HIV glycoprotein.
Previous investigations that addressed the significance of conserved N-linked glycosylation sites within the gp41 envelope glycoprotein used the infectious HXB2 clone of HIV-1. These investigations showed that processing and expression of the viral envelope were not drastically affected by the removal of glycosylation sites, but impairment of viral infectivity was observed (Dedera et al., 1992; Lee et al., 1992) . Conversely, Cao et al. (1993) reported that the individual mutation of two glycosylation consensus sequences at positions 626 (Thr to Met) or 639 (Thr to Ala), numerically the third and fourth glycosylation sites in gp41 of the HXB2c strain of HIV-1, dramatically affected the processing of gpl60. The authors concluded, on the basis of the two aforementioned studies, in which precursor processing had occurred, that the mutations had probably caused conformational disruption at the mutated sites rather than loss of glycosylation.
A different approach to this question utilized a vaccinia virus-driven HIV-1 envelope expression system and involved the complete removal of a glycan cluster from gp41, comprising three N-linked glycosylation sites (Fenouillet et al., 1993) . The induced mutation caused a decline in the processing of gpl60 and a significant reduction in the ability of the envelope proteins to mediate fusion. The findings of our investigation are in accordance with this last study, in that a complete cessation of precursor gpl60 processing to yield functional envelope proteins was observed after one N-linked glycosylation site at position 642 had been removed; the individual removal of three other canonical N-linked glycosylation sites had no such effect and gave rise to cleavable precursor gpl60 which yielded functional forms of gp41 of reduced Mr, consistent with the loss of a single N-linked glycosylation site ( Fig. 3 and 6) . Removal of the glycosylation site at position 642, numerically the third in the sequence, prevented the formation of syncytia (Fig. 2, panel d) as a result of gpl60 being retained in an intracellular compartment, most probably the ER (Fig. 4, panel D) which is antecedent to the Golgi compartment where the enzyme that catalyses the proteolytic cleavage of gpl60 resides (Willey et al., 1988a; Bosch & Pawilta, 1990; Morikawa et al., 1993 ). An analogous effect upon the proteolytic processing of gpl60 has been observed when deoxynorjirimycin (DNM), an inhibitor of glucosidase I resident in the rough ER (Kornfeld & Kornfeld, 1985) , was administered to cells infected with HIV-1 (Pal et al., 1989a) . Administration of DNM also reduced the 
)). A similar block in ER to
Golgi transport has been observed for the haemagglutinin (HA) of fo\vl plague virus to which a novel glycosylation site had been added (Schuy e1 a/., 1986) . The effect of this mutation gave rise to a temperaturesensitive strain of the virus in which the HA molecule. due to steric hindrance, could no longer trirnerize, an event which occurs in the ER and is necessary for the transport of the molecule to the Golgi. Removal of a single glycosylation site. as shown in this investigation, may cause a similar event to occur if it prevented oligomerization of the HIV-1 envelope proteins , 1985) . Removal of glucose from N-linked glycosylation sites is required for the efficient ER to Golgi transport of certain secretory proteins (Lodish & Kong, 1984) . It is also possible that mutation of the amino acid from asparagine to serine at position 642 could directly affect the conformation of the precursor molecule and result in the same effects.
